{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:50:09Z","timestamp":1790952609562,"version":"4.1.0"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"Importance<\/jats:title>No clinically applicable diagnostic test exists for severe mental disorders. Lipids harbor potential as disease markers.<\/jats:p><\/jats:sec>Objective<\/jats:title>To define a reproducible profile of lipid alterations in the blood plasma of patients with schizophrenia (SCZ) independent of demographic and environmental variables and to investigate its specificity in association with other psychiatric disorders, ie, major depressive disorder (MDD) and bipolar disorder (BPD).<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This was a multicohort case-control diagnostic analysis involving plasma samples from psychiatric patients and control individuals collected between July 17, 2009, and May 18, 2018. Study participants were recruited as consecutive and volunteer samples at multiple inpatient and outpatient mental health hospitals in Western Europe (Germany and Austria [DE-AT]), China (CN), and Russia (RU). Individuals with DSM-IV<\/jats:italic> or International Statistical Classification of Diseases and Related Health Problems, Tenth Revision<\/jats:italic> diagnoses of SCZ, MDD, BPD, or a first psychotic episode, as well as age- and sex-matched healthy controls without a mental health\u2013related diagnosis were included in the study. Samples and data were analyzed from January 2018 to September 2020.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Plasma lipidome composition was assessed using liquid chromatography coupled with untargeted mass spectrometry.<\/jats:p><\/jats:sec>Results<\/jats:title>Blood lipid levels were assessed in 980 individuals (mean [SD] age, 36 [13] years; 510 male individuals [52%]) diagnosed with SCZ, BPD, MDD, or those with a first psychotic episode and in 572 controls (mean [SD] age, 34 [13] years; 323 male individuals [56%]). A total of 77 lipids were found to be significantly altered between those with SCZ (n = 436) and controls (n = 478) in all 3 sample cohorts. Alterations were consistent between cohorts (CN and RU: [Pearson correlation] r<\/jats:italic>\u2009=\u20090.75; DE-AT and CN: r <\/jats:italic>= 0.78; DE-AT and RU: r <\/jats:italic>= 0.82; P<\/jats:italic>\u2009&amp;lt;\u200910\u221238<\/jats:sup>). A lipid-based predictive model separated patients with SCZ from controls with high diagnostic ability (area under the receiver operating characteristic curve\u2009=\u20090.86-0.95). Lipidome alterations in BPD and MDD, assessed in 184 and 256 individuals, respectively, were found to be similar to those of SCZ (BPD: r<\/jats:italic>\u2009=\u20090.89; MDD: r =<\/jats:italic> 0.92; P<\/jats:italic>\u2009&amp;lt;\u200910\u221279<\/jats:sup>). Assessment of detected alterations in individuals with a first psychotic episode, as well as patients with SCZ not receiving medication, demonstrated only limited association with medication restricted to particular lipids.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this study, SCZ was accompanied by a reproducible profile of plasma lipidome alterations, not associated with symptom severity, medication, and demographic and environmental variables, and largely shared with BPD and MDD. This lipid alteration signature may represent a trait marker of severe psychiatric disorders, indicating its potential to be transformed into a clinically applicable testing procedure.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2022.4350","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T16:08:38Z","timestamp":1674662918000},"page":"250","source":"Crossref","is-referenced-by-count":75,"title":["Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, Depression, and Bipolar Disorder"],"prefix":"10.1001","volume":"80","author":[{"given":"Anna","family":"Tkachev","sequence":"first","affiliation":[{"name":"Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia"},{"name":"Institute for Information Transmission Problems, Russian Academy of Sciences, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Stekolshchikova","sequence":"additional","affiliation":[{"name":"Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vanyushkina","sequence":"additional","affiliation":[{"name":"Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanping","family":"Zhang","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"},{"name":"Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Morozova","sequence":"additional","affiliation":[{"name":"Department Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Moscow, Russia"},{"name":"Moscow Psychiatric Hospital No. 1, named after N.A. Alekseev, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Zozulya","sequence":"additional","affiliation":[{"name":"Mental Health Research Center, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilia","family":"Kurochkin","sequence":"additional","affiliation":[{"name":"Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickolay","family":"Anikanov","sequence":"additional","affiliation":[{"name":"Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Egorova","sequence":"additional","affiliation":[{"name":"Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Yushina","sequence":"additional","affiliation":[{"name":"Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia"},{"name":"FSBSI N.P. Bochkov Research Center of Medical Genetics, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vogl","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Senner","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"},{"name":"Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina K.","family":"Schaupp","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Reich-Erkelenz","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Papiol","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"},{"name":"Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba Oraki","family":"Kohshour","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"},{"name":"Department of Immunology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farahnaz","family":"Kl\u00f6hn-Saghatolislam","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos L.","family":"Kalman","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"},{"name":"Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Heilbronner","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Heilbronner","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Gade","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley L.","family":"Comes","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Budde","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Anderson-Schmidt","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Adorjan","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"},{"name":"Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"},{"name":"German Center for Neurodegenerative Diseases, G\u00f6ttingen, Germany"},{"name":"Neurosciences and Signaling Group, Institute of Medicine, Department of Medical Sciences, University of Aveiro, Aveiro, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Z.","family":"Reininghaus","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for Neurobiology and Anthropometrics in Bipolar Affective Disorder, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Juckel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Dannlowski","sequence":"additional","affiliation":[{"name":"Institute for Translational Psychiatry, University of M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Fallgatter","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, T\u00fcbingen Center for Mental Health, University T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Spitzer","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Schmau\u00df","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Bezirkskrankenhaus Augsburg, Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"von Hagen","sequence":"additional","affiliation":[{"name":"Clinic for Psychiatry and Psychotherapy, Clinical Center Werra-Mei\u00dfner, Eschwege, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Zorkina","sequence":"additional","affiliation":[{"name":"Department Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Moscow, Russia"},{"name":"Moscow Psychiatric Hospital No. 1, named after N.A. Alekseev, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Reznik","sequence":"additional","affiliation":[{"name":"Moscow Psychiatric Hospital No. 1, named after N.A. Alekseev, Moscow, Russia"},{"name":"Moscow State University of Food Production, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Barkhatova","sequence":"additional","affiliation":[{"name":"Mental Health Research Center, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Lisov","sequence":"additional","affiliation":[{"name":"Institute for Information Transmission Problems, Russian Academy of Sciences, Moscow, Russia"},{"name":"Moscow Institute of Physics and Technology, Dolgoprudny, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Mokrov","sequence":"additional","affiliation":[{"name":"Moscow Institute of Physics and Technology, Dolgoprudny, Russia"},{"name":"Center for Artificial Intelligence Technologies, Skolkovo Institute of Science and Technology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Panov","sequence":"additional","affiliation":[{"name":"Technology Innovation Institute, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Zubkov","sequence":"additional","affiliation":[{"name":"Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Petrova","sequence":"additional","affiliation":[{"name":"Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanjuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"},{"name":"Department of Neurology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Liu","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juncai","family":"Pu","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Falkai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiy","family":"Kostyuk","sequence":"additional","affiliation":[{"name":"Moscow Psychiatric Hospital No. 1, named after N.A. Alekseev, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Klyushnik","sequence":"additional","affiliation":[{"name":"Mental Health Research Center, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Schulze","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"},{"name":"Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, New York"},{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xie","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"},{"name":"Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"},{"name":"Chongqing Key Laboratory of Neurobiology, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva C.","family":"Schulte","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"},{"name":"Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany"},{"name":"Department of Psychiatry and Psychotherapy, University Hospital Bonn, medical Faculty University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Khaitovich","sequence":"additional","affiliation":[{"name":"Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"yoi220085r1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/wps.v12.3","article-title":"A meta-analysis of cardiometabolic abnormalities in drug na\u00efve, first-episode and multiepisode patients with schizophrenia vs general population controls.","volume":"12","author":"Vancampfort","year":"2013","journal-title":"World Psychiatry"},{"issue":"6","key":"yoi220085r2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1192\/bjp.bp.117.200907","article-title":"Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis.","volume":"211","author":"Pillinger","year":"2017","journal-title":"Br J Psychiatry"},{"key":"yoi220085r3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.schres.2017.03.031","article-title":"Lipid profile disturbances in antipsychotic-naive patients with first-episode nonaffective psychosis: a systematic review and meta-analysis.","volume":"190","author":"Misiak","year":"2017","journal-title":"Schizophr Res"},{"key":"yoi220085r4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jad.2020.01.114","article-title":"Cholesterol and triglyceride levels in first-episode patients with major depressive disorder: a meta-analysis of case-control studies.","volume":"266","author":"Wei","year":"2020","journal-title":"J Affect Disord"},{"issue":"3","key":"yoi220085r5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.psychres.2012.02.019","article-title":"Impaired plasmalogens in patients with schizophrenia.","volume":"198","author":"Kaddurah-Daouk","year":"2012","journal-title":"Psychiatry Res"},{"key":"yoi220085r6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.psychres.2018.12.008","article-title":"Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia.","volume":"272","author":"Wang","year":"2019","journal-title":"Psychiatry Res"},{"issue":"6","key":"yoi220085r7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11306-018-1375-3","article-title":"Unbiased lipidomic profiling reveals metabolomic changes during the onset and antipsychotics treatment of schizophrenia disease.","volume":"14","author":"Yan","year":"2018","journal-title":"Metabolomics"},{"issue":"1","key":"yoi220085r8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00406-018-0971-6","article-title":"Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis.","volume":"270","author":"Leppik","year":"2020","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2-3","key":"yoi220085r9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.schres.2014.11.032","article-title":"Dysfunctional plasmalogen dynamics in the plasma and platelets of patients with schizophrenia.","volume":"161","author":"Wood","year":"2015","journal-title":"Schizophr Res"},{"issue":"3","key":"yoi220085r10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/15622975.2020.1769188","article-title":"Characterising phospholipids and free fatty acids in patients with schizophrenia: a case-control study.","volume":"22","author":"Wang","year":"2021","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"yoi220085r11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41398-018-0353-x","article-title":"Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and posttreatment study.","volume":"9","author":"Cao","year":"2019","journal-title":"Transl Psychiatry"},{"issue":"3","key":"yoi220085r12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/pcn.2019.73.issue-3","article-title":"Serum metabolic profiling using small molecular water-soluble metabolites in individuals with schizophrenia: a longitudinal study using a pre-posttreatment design.","volume":"73","author":"Cao","year":"2019","journal-title":"Psychiatry Clin Neurosci"},{"issue":"10","key":"yoi220085r13","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1021\/acs.jproteome.7b00279","article-title":"Profiling of acylcarnitines in first episode psychosis before and after antipsychotic treatment.","volume":"16","author":"Kriisa","year":"2017","journal-title":"J Proteome Res"},{"issue":"5","key":"yoi220085r14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/15622975.2019.1615639","article-title":"Metabolic profiling for water-soluble metabolites in patients with schizophrenia and healthy controls in a Chinese population: a case-control study.","volume":"21","author":"Cao","year":"2020","journal-title":"World J Biol Psychiatry"},{"issue":"6","key":"yoi220085r15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/15622975.2016.1178803","article-title":"Comparison of serum carnitine levels and clinical correlates between outpatients and acutely hospitalised individuals with bipolar disorder and schizophrenia: a cross-sectional study.","volume":"17","author":"Cuturic","year":"2016","journal-title":"World J Biol Psychiatry"},{"key":"yoi220085r16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.eurpsy.2017.02.479","article-title":"The lipidome in major depressive disorder: shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk.","volume":"43","author":"Knowles","year":"2017","journal-title":"Eur Psychiatry"},{"issue":"3","key":"yoi220085r17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jpsychires.2012.11.001","article-title":"Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family\u2013based lipidomics study.","volume":"47","author":"Demirkan","year":"2013","journal-title":"J Psychiatr Res"},{"issue":"23","key":"yoi220085r18","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1007\/s00216-016-9768-5","article-title":"Plasma lipidomics reveals potential lipid markers of major depressive disorder.","volume":"408","author":"Liu","year":"2016","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"yoi220085r19","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1021\/acs.jproteome.5b00144","article-title":"Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.","volume":"14","author":"Liu","year":"2015","journal-title":"J Proteome Res"},{"key":"yoi220085r20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.metabol.2019.04.002","article-title":"Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorder.","volume":"95","author":"Brunkhorst-Kanaan","year":"2019","journal-title":"Metabolism"},{"key":"yoi220085r21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jad.2017.02.008","article-title":"Ceramides and depression: a systematic review.","volume":"213","author":"Dinoff","year":"2017","journal-title":"J Affect Disord"},{"key":"yoi220085r22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.psychres.2018.04.029","article-title":"Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients.","volume":"265","author":"Kim","year":"2018","journal-title":"Psychiatry Res"},{"key":"yoi220085r23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2017.12.025","article-title":"Alterations in peripheral fatty acid composition in bipolar and unipolar depression.","volume":"233","author":"Scola","year":"2018","journal-title":"J Affect Disord"},{"issue":"5","key":"yoi220085r24","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3390\/biom11050720","article-title":"Shorter chain triglycerides are negatively associated with symptom improvement in schizophrenia.","volume":"11","author":"Tkachev","year":"2021","journal-title":"Biomolecules"},{"key":"yoi220085r26","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.76","article-title":"Schizophrenia shows a unique metabolomics signature in plasma.","volume":"2","author":"He","year":"2012","journal-title":"Transl Psychiatry"},{"issue":"2","key":"yoi220085r27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1176\/jnp.23.2.jnp215","article-title":"Elevated plasma ceramides in depression.","volume":"23","author":"Gracia-Garcia","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"22","key":"yoi220085r28","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1007\/s00216-019-01956-2","article-title":"Quantitative monitoring of a panel of stress-induced biomarkers in human plasma by liquid chromatography-tandem mass spectrometry: an application in a comparative study between depressive patients and healthy subjects.","volume":"411","author":"Cai","year":"2019","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"yoi220085r29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","article-title":"KEGG: Kyoto encyclopedia of genes and genomes.","volume":"27","author":"Ogata","year":"1999","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"yoi220085r30","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1038\/s41467-019-11954-8","article-title":"Genetic architecture of human plasma lipidome and its link to cardiovascular disease.","volume":"10","author":"Tabassum","year":"2019","journal-title":"Nat Commun"},{"issue":"10","key":"yoi220085r31","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1194\/jlr.S087163","article-title":"MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines.","volume":"59","author":"Burla","year":"2018","journal-title":"J Lipid Res"},{"issue":"2","key":"yoi220085r32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"issue":"database issue","key":"yoi220085r33","doi-asserted-by":"publisher","first-page":"D799","DOI":"10.1093\/nar\/gku1202","article-title":"GRASP v2.0: an update on the Genome-Wide Repository of Associations between SNPs and phenotypes.","volume":"43","author":"Eicher","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"yoi220085r34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fpsyt.2018.00209","article-title":"Blood-based lipidomics approach to evaluate biomarkers associated with response to olanzapine, risperidone, and quetiapine treatment in schizophrenia patients.","volume":"9","author":"Aquino","year":"2018","journal-title":"Front Psychiatry"},{"issue":"11","key":"yoi220085r35","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.222","article-title":"Serum metabolite profile associates with the development of metabolic comorbidities in first-episode psychosis.","volume":"6","author":"Suvitaival","year":"2016","journal-title":"Transl Psychiatry"},{"issue":"7","key":"yoi220085r36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068717","article-title":"Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics.","volume":"8","author":"McEvoy","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"yoi220085r37","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2019.11.020","article-title":"Genomic relationships, novel loci, and pleiotropic mechanisms across 8 psychiatric disorders.","volume":"179","author":"Cross-Disorder Group of the Psychiatric Genomics Consortium","year":"2019","journal-title":"Cell"},{"issue":"6395","key":"yoi220085r38","doi-asserted-by":"publisher","DOI":"10.1126\/science.aap8757","article-title":"Analysis of shared heritability in common disorders of the brain.","volume":"360","author":"Anttila","year":"2018","journal-title":"Science"},{"issue":"11","key":"yoi220085r39","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.biopsych.2009.10.008","article-title":"Endophenotypes: bridging genomic complexity and disorder heterogeneity.","volume":"66","author":"Insel","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"9","key":"yoi220085r40","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/ng.2711","article-title":"Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.","volume":"45","author":"Lee","year":"2013","journal-title":"Nat Genet"},{"issue":"7","key":"yoi220085r41","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.cell.2018.05.046","article-title":"Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes.","volume":"173","author":"Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium","year":"2018","journal-title":"Cell"},{"issue":"5","key":"yoi220085r42","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/acps.2018.137.issue-5","article-title":"The relationship between negative symptoms and depression in schizophrenia: a systematic review.","volume":"137","author":"Krynicki","year":"2018","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"yoi220085r43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0193-953X(02)00085-0","article-title":"Boundaries of schizophrenia.","volume":"26","author":"Adler","year":"2003","journal-title":"Psychiatr Clin North Am"},{"issue":"1","key":"yoi220085r44","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41398-020-01084-x","article-title":"Key role for lipids in cognitive symptoms of schizophrenia.","volume":"10","author":"Maas","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"2","key":"yoi220085r45","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders: a systematic review and meta-analysis.","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr Bull"},{"issue":"1","key":"yoi220085r46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.31887\/DCNS.2018.20.1\/bpenninx","article-title":"Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications.","volume":"20","author":"Penninx","year":"2018","journal-title":"Dialogues Clin Neurosci"},{"issue":"6","key":"yoi220085r47","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.eurpsy.2009.01.005","article-title":"Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC).","volume":"24","author":"De Hert","year":"2009","journal-title":"Eur Psychiatry"},{"issue":"1","key":"yoi220085r48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.31887\/DCNS.2018.20.1\/nsartorius","article-title":"Depression and diabetes.","volume":"20","author":"Sartorius","year":"2018","journal-title":"Dialogues Clin Neurosci"},{"issue":"2","key":"yoi220085r49","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jacl.2020.01.005","article-title":"Ceramides and risk of major adverse cardiovascular events: a meta-analysis of longitudinal studies.","volume":"14","author":"Mantovani","year":"2020","journal-title":"J Clin Lipidol"},{"key":"yoi220085r25","doi-asserted-by":"crossref","unstructured":"Korotkevich? G, Sukhov? V, Budin? N, Shpak? B, Artyomov? MN, Sergushichev? A. Fast gene set enrichment analysis.? BioRxiv. Preprint posted online February 1, 2021. doi:10.1101\/060012","DOI":"10.1101\/060012"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2800311\/jamapsychiatry_tkachev_2023_oi_220085_1677529730.06343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T16:01:27Z","timestamp":1677686487000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2800311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.4350","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}